Expertise in
20
conditions

Christophe Richez

Bordeaux, FR 
Expertise in
20
conditions
Bordeaux, FR 

Overview

Christophe Richez practices practicing medicine in Bordeaux, France.

Mr. Richez is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Systemic Lupus Erythematosus (SLE), and Rheumatoid Lung Disease.

He is actively involved in clinical research, co-authoring 202 peer reviewed articles and participating in 16 clinical trials.

Gender

Male

Locations

Bordeaux, France
Other Locations
Lille, 59000, France
Brest, France
Strasbourg, France
Montpellier, France
Clermont-ferrand, France
Paris, France
Nantes, France
Limoges, France
Lyon, France
Pessac-sur-dordogne, 33600, France
Tours, 37000, France
Nancy, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

16 Clinical Trials

Soluble CD95 Ligand Role in the Pathophysiology of ANCA Associated Vasculitis
Soluble CD95 Ligand Role in the Pathophysiology of ANCA Associated Vasculitis
Enrollment Status: Completed
Publish Date: August 17, 2026
Intervention Type: Biological
Study Phase: Not Applicable
Randomized Placebo-controlled Trial Comparing Methotrexate vs. Methotrexate/Metformin Association in Rheumatoid Arthritis Patients
Randomized Placebo-controlled Trial Comparing Methotrexate vs. Methotrexate/Metformin Association in Rheumatoid Arthritis Patients
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Other, Drug
Study Drugs: Metformin, Methotrexate
Study Phase: Phase 2
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: June 24, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
Cartography and Quantitative Characterization of Achilles Tendon Fibrocartilage by TE = 0ms Imaging at3T MRI
Cartography and Quantitative Characterization of Achilles Tendon Fibrocartilage by TE = 0ms Imaging at3T MRI
Enrollment Status: Completed
Publish Date: June 01, 2026
Intervention Type: Device
Study Phase: Not Applicable
Involvement of Immune Cells Derived From the Intestine in Sjogren's Syndrome
Involvement of Immune Cells Derived From the Intestine in Sjogren's Syndrome
Enrollment Status: Completed
Publish Date: May 20, 2026
Intervention Type: Biological
Study Drugs: Blood sample, Biopsy of the labial salivary gland
Study Phase: Not Applicable
Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis
Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis
Enrollment Status: Completed
Publish Date: May 14, 2026
Intervention Type: Biological
Study Phase: Not Applicable
Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous
Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous
Enrollment Status: Completed
Publish Date: May 14, 2026
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Dietary Phytoestrogens in Blood and Urine of Female Patient With Acute Systemic Lupus Erythematosus
Dietary Phytoestrogens in Blood and Urine of Female Patient With Acute Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: May 14, 2026
Intervention Type: Other
Study Phase: Not Applicable
Combination of Baricitinib and Anti-TNF vs. Baricitinib in Patients With Rheumatoid Arthritis: a Randomized Controlled Phase III Trial
Combination of Baricitinib and Anti-TNF vs. Baricitinib in Patients With Rheumatoid Arthritis: a Randomized Controlled Phase III Trial
Enrollment Status: Active_not_recruiting
Publish Date: March 17, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, Adalimumab
Study Phase: Phase 3
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases
Enrollment Status: Active_not_recruiting
Publish Date: February 03, 2026
Intervention Type: Biological, Other, Behavioral
Study Phase: Not Applicable
View 9 Less Clinical Trials

202 Total Publications

Answer to Elbaz et al.
Answer to Elbaz et al.
Journal: Joint bone spine
Published: June 14, 2026

Frequently Asked Questions about Christophe Richez

Is Christophe Richez a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Christophe Richez is classified as an Elite expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Christophe Richez participate in research or clinical trials?

Yes. Christophe Richez has published 202 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Christophe Richez's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Richez's expertise for a condition
ConditionClose
View All 14 Advanced Conditions
View All 48 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile